ALEUP.PA
Europlasma S.A. [ALEUP.PA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALEUP.PA Stock Summary
Top 10 Correlated ETFs
ALEUP.PA
Top 10 Correlated Stocks
ALEUP.PA
In the News
ALEUP.PA Financial details
Company Rating
Neutral
Market Cap
1.43M
Income
-19.99M
Revenue
28.48M
Book val./share
0.04
Cash/share
0.4
Dividend
-
Dividend %
-
Employees
187
Optionable
No
Shortable
Yes
Earnings
22 Apr 2024
P/E
-1.54
Forward P/E
-
PEG
0.17
P/S
0.09
P/B
3.69
P/C
0
P/FCF
-0.16
Quick Ratio
0.38
Current Ratio
0.62
Debt / Equity
21.41
LT Debt / Equity
-8.75
-
-
EPS (TTM)
-340.75
EPS next Y
-
EPS next Q
-
EPS this Y
-99.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-91.33%
Revenue last 5Y
0.77%
Revenue Q/Q
-1.52%
EPS Q/Q
-90.91%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-29%
ROE
-264%
ROC
-0.59%
Gross Margin
39%
Oper. Margin
-111%
Profit Margin
-108%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.0E-4-0.77
52W High
-
52W Low
-
RSI
32
Rel Volume
0.4
Avg Volume
136.15M
Volume
54.16M
Perf Week
-20%
Perf Month
-66.67%
Perf Quarter
-91.3%
Perf Half Y
-92.86%
-
-
-
-
Beta
1.317
-
-
Volatility
0%, 0%
Prev Close
-20%
Price
0.0004
Change
-20%
ALEUP.PA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.39M | 166.97K | 29.6 | 3.27K | 24 | |
| Net income per share | -5.36M | -562.23K | -77.07 | -4.23K | -26.32 | |
| Operating cash flow per share | -1.28M | -369.89K | -96.22 | -6.11K | -17.32 | |
| Free cash flow per share | -1.5M | -397.59K | -133.46 | -7.92K | -22.12 | |
| Cash per share | 395.62K | 144.67K | 32.53 | 829.82 | 4 | |
| Book value per share | -3.35M | -1.61M | -121.51 | 1.78K | 10.84 | |
| Tangible book value per share | -4.05M | -2.07M | -129.1 | 1.43K | 9.34 | |
| Share holders equity per share | -3.35M | -1.61M | -121.51 | 1.78K | 10.84 | |
| Interest debt per share | 3.32M | 1.22M | 175.15 | 3.48K | 21.96 | |
| Market cap | 12.46M | 2.3M | 2.87B | 3.64M | 423.17K | |
| Enterprise value | 38.3M | 21.96M | 2.88B | 5.34M | 6.38M | |
| P/E ratio | -0.23 | -0.22 | -290.89 | -0.29 | -0.03 | |
| Price to sales ratio | 0.89 | 0.73 | 757.32 | 0.37 | 0.03 | |
| POCF ratio | -0.97 | -0.33 | -233.02 | -0.2 | -0.04 | |
| PFCF ratio | -0.82 | -0.31 | -167.99 | -0.15 | -0.03 | |
| P/B Ratio | -0.37 | -0.08 | -184.52 | 0.68 | 0.06 | |
| PTB ratio | -0.37 | -0.08 | -184.52 | 0.68 | 0.06 | |
| EV to sales | 2.74 | 6.97 | 758.22 | 0.54 | 0.44 | |
| Enterprise value over EBITDA | -5.81 | -1.89 | -249.91 | -0.58 | -0.56 | |
| EV to operating cash flow | -2.97 | -3.14 | -233.29 | -0.29 | -0.61 | |
| EV to free cash flow | -2.53 | -2.93 | -168.19 | -0.22 | -0.48 | |
| Earnings yield | -4.32 | -4.61 | 0 | -3.48 | -37.63 | |
| Free cash flow yield | -1.21 | -3.26 | -0.01 | -6.53 | -31.62 | |
| Debt to equity | -0.88 | -0.69 | -0.43 | 0.66 | 1.16 | |
| Debt to assets | 1.17 | 1.1 | 0.26 | 0.09 | 0.14 | |
| Net debt to EBITDA | -3.92 | -1.7 | -0.3 | -0.19 | -0.53 | |
| Current ratio | 0.37 | 0.34 | 0.37 | 0.62 | 0.62 | |
| Interest coverage | -12.58 | -7.46 | -0.79 | -1.69 | -2.89 | |
| Income quality | 0.24 | 0.66 | 1.25 | 1.45 | 0.66 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.34 | 0.65 | 0.5 | 0.37 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.01 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.17 | 0.07 | 0.39 | 0.3 | 0.28 | |
| Capex to revenue | -0.16 | -0.17 | -1.26 | -0.55 | -0.2 | |
| Capex to depreciation | -0.06 | -0.12 | -5.42 | -2.18 | -0.58 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.04 | 0 | |
| Graham number | 20.11M | 4.52M | 459.03 | 13.03K | 80.14 | |
| ROIC | 11.72 | 1.95 | 1.44 | -1.19 | -1.08 | |
| Return on tangible assets | -2.12 | -0.56 | -0.38 | -0.31 | -0.29 | |
| Graham Net | -5.87M | -2.63M | -258.88 | -9.24K | -62.13 | |
| Working capital | -26.56M | -22.08M | -20.37M | -8.29M | -10.44M | |
| Tangible asset value | -40.7M | -39.07M | -16.55M | 4.29M | 5.65M | |
| Net current asset value | -50.5M | -46.64M | -30.65M | -22.61M | -31.85M | |
| Invested capital | -0.88 | -0.69 | -0.43 | 0.66 | 1.16 | |
| Average receivables | 4.86M | 5.13M | 6.78M | 6.16M | 6.53M | |
| Average payables | 5.05M | 5.67M | 3.77M | 2.58M | 3.42M | |
| Average inventory | 1.41M | 1.13M | 921.5K | 1.91M | 4.82M | |
| Days sales outstanding | 87.37 | 800.15 | 638.92 | 211.35 | 185.44 | |
| Days payables outstanding | 200.22 | 121.15 | 63.28 | 55.91 | 50.01 | |
| Days of inventory on hand | 41.03 | 23.21 | 23.6 | 56.59 | 85.57 | |
| Receivables turnover | 4.18 | 0.46 | 0.57 | 1.73 | 1.97 | |
| Payables turnover | 1.82 | 3.01 | 5.77 | 6.53 | 7.3 | |
| Inventory turnover | 8.9 | 15.72 | 15.47 | 6.45 | 4.27 | |
| ROE | 1.6 | 0.35 | 0.63 | -2.37 | -2.43 | |
| Capex per share | -223.08K | -27.7K | -37.24 | -1.81K | -4.8 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.83K | 965.39 | 348.13 | 1.78 | 0.84 | |
| Net income per share | -6.75K | -219.84 | -117.31 | -3.3 | -0.3 | |
| Operating cash flow per share | -6.03K | -1.19K | -539.66 | 0.18 | -0.53 | |
| Free cash flow per share | -7.55K | -1.61K | -632.36 | -0.06 | -0.61 | |
| Cash per share | 1.15K | 353.79 | 61.11 | 0.59 | 0.4 | |
| Book value per share | -4.27K | 760.9 | 754.23 | 1.6 | 0.04 | |
| Tangible book value per share | -4.92K | 610.03 | 708.41 | 1.38 | -0.06 | |
| Share holders equity per share | -4.27K | 760.9 | 754.23 | 1.6 | 0.04 | |
| Interest debt per share | 4.11K | 841.39 | 252.16 | 2.8 | 1.04 | |
| Market cap | 8.97M | 8.54M | 582.4K | 2.86M | 1.34M | |
| Enterprise value | 10.09M | 10.24M | 3.23M | 8.81M | 6.2M | |
| P/E ratio | -0.2 | -1.38 | -0.06 | -0.05 | -0.13 | |
| Price to sales ratio | 2.97 | 1.26 | 0.08 | 0.39 | 0.19 | |
| POCF ratio | -0.9 | -1.02 | -0.05 | 3.82 | -0.3 | |
| PFCF ratio | -0.72 | -0.75 | -0.04 | -12.6 | -0.26 | |
| P/B Ratio | -1.27 | 1.6 | 0.04 | 0.44 | 3.51 | |
| PTB ratio | -1.27 | 1.6 | 0.04 | 0.44 | 3.51 | |
| EV to sales | 3.35 | 1.51 | 0.45 | 1.21 | 0.87 | |
| Enterprise value over EBITDA | -1.75 | -2.87 | -0.61 | -1.3 | -0.95 | |
| EV to operating cash flow | -1.02 | -1.22 | -0.29 | 11.78 | -1.38 | |
| EV to free cash flow | -0.81 | -0.9 | -0.25 | -38.82 | -1.2 | |
| Earnings yield | -1.24 | -0.18 | -4.19 | -4.72 | -1.88 | |
| Free cash flow yield | -1.39 | -1.33 | -22.58 | -0.08 | -3.86 | |
| Debt to equity | -0.32 | 0.66 | 0.22 | 1.16 | 21.41 | |
| Debt to assets | 0.08 | 0.09 | 0.06 | 0.14 | 0.14 | |
| Net debt to EBITDA | -0.2 | -0.48 | -0.5 | -0.88 | -0.74 | |
| Current ratio | 0.42 | 0.62 | 0.74 | 0.62 | 0.63 | |
| Interest coverage | -1.47 | -2.11 | -4.11 | -2.3 | -12.09 | |
| Income quality | 0.89 | 5.43 | 4.6 | -0.06 | 1.79 | |
| Dividend Yield | 0 | 0 | 0 | 1.67 | 0 | |
| Payout ratio | 0 | 0 | 0 | -0.35 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0.25 | 0.35 | 0.17 | -1.3 | 0.15 | |
| Capex to revenue | -0.83 | -0.43 | -0.27 | -0.13 | -0.09 | |
| Capex to depreciation | -2.83 | -2.05 | -0.86 | -0.49 | -0.33 | |
| Stock based compensation to revenue | 0.06 | 0.03 | 0.03 | -0.03 | 0 | |
| Graham number | 25.48K | 1.94K | 1.41K | 10.91 | 0.54 | |
| ROIC | 1.68 | -0.43 | -0.46 | -0.56 | -0.84 | |
| Return on tangible assets | -0.41 | -0.04 | -0.05 | -0.25 | -0.04 | |
| Graham Net | -17.59K | -3.94K | -1.43K | -9.2 | -5.12 | |
| Working capital | -14.87M | -8.29M | -5.72M | -10.44M | -12.15M | |
| Tangible asset value | -8.11M | 4.29M | 14.74M | 5.65M | -511K | |
| Net current asset value | -24.54M | -22.61M | -22.44M | -31.85M | -36.14M | |
| Invested capital | -0.32 | 0.66 | 0.22 | 1.16 | 21.41 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 158.69 | 75.26 | 94.21 | 91.21 | 95.35 | |
| Days payables outstanding | 23.04 | 25.03 | 26.6 | 24.44 | 41.73 | |
| Days of inventory on hand | 9.48 | 25.33 | 24.85 | 41.81 | 55.17 | |
| Receivables turnover | 0.57 | 1.2 | 0.96 | 0.99 | 0.94 | |
| Payables turnover | 3.91 | 3.6 | 3.38 | 3.68 | 2.16 | |
| Inventory turnover | 9.5 | 3.55 | 3.62 | 2.15 | 1.63 | |
| ROE | 1.58 | -0.29 | -0.16 | -2.06 | -6.61 | |
| Capex per share | -1.52K | -413.94 | -92.69 | -0.24 | -0.08 |
ALEUP.PA Frequently Asked Questions
What is Europlasma S.A. stock symbol ?
Europlasma S.A. is a FR stock and trading under the symbol ALEUP.PA
What is Europlasma S.A. stock quote today ?
Europlasma S.A. stock price is $0.0004 today.
Is Europlasma S.A. stock public?
Yes, Europlasma S.A. is a publicly traded company.
Company Profile
- Volume Average 136.15M
- Market Capitalization 1.43M
- Employee 187
- CEO Mr. Jérôme Garnache-Creuillot
- Headquarters Pessac,FR
- IPO Date 2001-10-01
-
Website
https://www.europlasma.com 
Europlasma S.A., together with its subsidiaries, engages in developing, constructing, and operating of the plasma torch system for industrial applications in France. It offers plasma solutions for gas and hazardous wastes. The company also engages in the production of renewable energy from waste and biomass; and provides asbestos waste treatment services, such as collection, transport, neutralization, and recovery services for hazardous waste. Europlasma S.A. was founded in 1992 and is based in Pessac, France.
